The success of Sildenafil initially sparked a period of growth for pharma, nevertheless recent shifts present a complicated outlook for those considering a stake. Off-patent alternatives are eating into revenue, and https://brendanelq568029.blogunok.com/41430678/sildenafil-and-the-pharmaceutical-industry-a-volatile-play